Format

Send to

Choose Destination
BMC Musculoskelet Disord. 2011 Feb 23;12:50. doi: 10.1186/1471-2474-12-50.

Valvular involvement in ANCA-associated systemic vasculitis: a case report and literature review.

Author information

1
Assistance Publique Hôpitaux de Paris (AP-HP), department of internal medicine, Ambroise Paré Hospital, 9, avenue Charles-de-Gaulle, 92100, Boulogne Billancourt, France.

Abstract

BACKGROUND:

Antineutrophil cytoplasmic antibodies (ANCA)-associated systemic vasculitides have a variety of presentations, but cardiac valvular involvement is rarely diagnosed and its management is not established.

CASE PRESENTATION:

We report the case of a 44 year old man who presented with an ANCA-associated systemic vasculitis and aortic regurgitation of unusual mechanism. Transthoracic and transesophageal echocardiography disclosed septal hypertrophy preventing a complete closure of the aortic valve and thus responsible for a massive aortic regurgitation. After 4 months of immunosuppressive therapy, the valve lesion did not subside and the patient had to undergo aortic valve replacement. This report also reviews the 20 cases of systemic ANCA-associated vasculitis with endocardial valvular involvement previously reported in the English language medical literature.

CONCLUSIONS:

Valvular involvement in ANCA-associated systemic vasculitides is rarely reported. Most of these lesions are due to Wegener's granulomatosis and half are present when the diagnosis of vasculitis is made. The valvular lesion is usually isolated, aortic regurgitation being the most frequent type, and often requires valve replacement in the months that follow it's discovery.

PMID:
21345235
PMCID:
PMC3050781
DOI:
10.1186/1471-2474-12-50
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center